|
|
||||||||
Department of Immunology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
PGE2 has been known to suppress Th1 responses. We
studied the role of PGE2 in two representative chemokines,
macrophage-derived chemokine (MDC) and IFN-inducible protein-10,
production by LPS- or CD40-stimulated spleen cells. The production of
MDC, one of the ligands for CCR4 preferentially expressed on Th2, was
enhanced in nonstimulated, LPS-, CD40-, or CD3-stimulated spleen cells
by the pretreatment with PGE2, while the production of
IFN-inducible protein-10, a representative ligand for CXC chemokine
receptor 3 expressed on Th1, was suppressed. MDC production was also
enhanced by IL-4, IL-5, and intracellular cAMP-elevating agents such as
dibutyryl cAMP and 3-isobutyl-1-methylxanthine, and the effect of IL-4,
IL-5, and PGE2 was additive. However, the pretreatment with
IL-6, IL-10, or TGF-
, or the neutralization of IFN-
or IL-12 had
no effect on MDC production. B cells, macrophages, and dendritic cells
were main producers of MDC, while T cells produced only a small amount
of MDC. MDC production by B cells was equally stimulated by LPS and
anti-CD40 Ab, while that by macrophages and dendritic cells was
more markedly stimulated by anti-CD40 Ab, and PGE2
further enhanced MDC production by these stimulated cells. These
results indicate that PGE2 regulates Th1/Th2-related
chemokine production by B cells, macrophages, and dendritic cells, and
that this is a new function of PGE2 for the regulation of
Th2 immune responses at the induction and activation
stages.
This article has been cited by other articles:
![]() |
W. Ding, L. L. Stohl, J. A. Wagner, and R. D. Granstein Calcitonin Gene-Related Peptide Biases Langerhans Cells toward Th2-Type Immunity J. Immunol., November 1, 2008; 181(9): 6020 - 6026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xin, S. Dziadek, D. R. Bundle, and J. E. Cutler Synthetic glycopeptide vaccines combining {beta}-mannan and peptide epitopes induce protection against candidiasis PNAS, September 9, 2008; 105(36): 13526 - 13531. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Muthuswamy, J. Urban, J.-J. Lee, T. A. Reinhart, D. Bartlett, and P. Kalinski Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation Cancer Res., July 15, 2008; 68(14): 5972 - 5978. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Khayrullina, J.-H. Yen, H. Jing, and D. Ganea In Vitro Differentiation of Dendritic Cells in the Presence of Prostaglandin E2 Alters the IL-12/IL-23 Balance and Promotes Differentiation of Th17 Cells J. Immunol., July 1, 2008; 181(1): 721 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Ospelt, M Kurowska-Stolarska, M Neidhart, B A Michel, R E Gay, S Laufer, and S Gay The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands Ann Rheum Dis, April 1, 2008; 67(4): 524 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lattin, D. A. Zidar, K. Schroder, S. Kellie, D. A. Hume, and M. J. Sweet G-protein-coupled receptor expression, function, and signaling in macrophages J. Leukoc. Biol., July 1, 2007; 82(1): 16 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mariani, S. Gilles, T. Jakob, M. Thiel, M. J. Mueller, J. Ring, H. Behrendt, and C. Traidl-Hoffmann Immunomodulatory Mediators from Pollen Enhance the Migratory Capacity of Dendritic Cells and License Them for Th2 Attraction J. Immunol., June 15, 2007; 178(12): 7623 - 7631. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Siciliano, J. A. Skinner, and M. H. Yuk Bordetella bronchiseptica Modulates Macrophage Phenotype Leading to the Inhibition of CD4+ T Cell Proliferation and the Initiation of a Th17 Immune Response J. Immunol., November 15, 2006; 177(10): 7131 - 7138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. von Bergwelt-Baildon, A. Popov, T. Saric, J. Chemnitz, S. Classen, M. S. Stoffel, F. Fiore, U. Roth, M. Beyer, S. Debey, et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition Blood, July 1, 2006; 108(1): 228 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-N. Zhu, Y.-F. Yang, S. Ono, X.-G. Zhong, Y.-H. Feng, Y.-X. Ren, J. Ni, Y.-F. Fu, W. Tang, and J.-P. Zuo Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-{gamma} is associated with the activation of extracellular signal-related kinase Int. Immunol., June 1, 2006; 18(6): 981 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arras, J. Louahed, V. Simoen, V. Barbarin, P. Misson, S. van den Brule, M. Delos, L. Knoops, J.-C. Renauld, D. Lison, et al. B Lymphocytes Are Critical for Lung Fibrosis Control and Prostaglandin E2 Regulation in IL-9 Transgenic Mice Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 573 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Guriec, C. Daniel, K. Le Ster, E. Hardy, and C. Berthou Cytokine-regulated expression and inhibitory function of Fc{gamma}RIIB1 and -B2 receptors in human dendritic cells J. Leukoc. Biol., January 1, 2006; 79(1): 59 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Noguchi, E. Kuroda, and U. Yamashita Strain difference of murine bone marrow-derived mast cell functions J. Leukoc. Biol., September 1, 2005; 78(3): 605 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vassiliou, V. Sharma, H. Jing, F. Sheibanie, and D. Ganea Prostaglandin E2 Promotes the Survival of Bone Marrow-Derived Dendritic Cells J. Immunol., December 1, 2004; 173(11): 6955 - 6964. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jing, E. Vassiliou, and D. Ganea Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells J. Leukoc. Biol., November 1, 2003; 74(5): 868 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Delgado Inhibition of Interferon (IFN) {gamma}-induced Jak-STAT1 Activation in Microglia by Vasoactive Intestinal Peptide: INHIBITORY EFFECT ON CD40, IFN-INDUCED PROTEIN-10, AND INDUCIBLE NITRIC-OXIDE SYNTHASE EXPRESSION J. Biol. Chem., July 18, 2003; 278(30): 27620 - 27629. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Panther, S. Corinti, M. Idzko, Y. Herouy, M. Napp, A. la Sala, G. Girolomoni, and J. Norgauer Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells Blood, May 15, 2003; 101(10): 3985 - 3990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. la Sala, D. Ferrari, F. Di Virgilio, M. Idzko, J. Norgauer, and G. Girolomoni Alerting and tuning the immune response by extracellular nucleotides J. Leukoc. Biol., March 1, 2003; 73(3): 339 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kuroda and U. Yamashita Mechanisms of Enhanced Macrophage-Mediated Prostaglandin E2 Production and Its Suppressive Role in Th1 Activation in Th2-Dominant BALB/c Mice J. Immunol., January 15, 2003; 170(2): 757 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Metwali, A. Blum, D. E. Elliott, and J. V. Weinstock Interleukin-4 Receptor {alpha} Chain and STAT6 Signaling Inhibit Gamma Interferon but Not Th2 Cytokine Expression within Schistosome Granulomas Infect. Immun., October 1, 2002; 70(10): 5651 - 5658. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kuroda, T. Kito, and U. Yamashita Reduced Expression of STAT4 and IFN-{gamma} in Macrophages from BALB/c Mice J. Immunol., June 1, 2002; 168(11): 5477 - 5482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. la Sala, S. Sebastiani, D. Ferrari, F. Di Virgilio, M. Idzko, J. Norgauer, and G. Girolomoni Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes Blood, March 1, 2002; 99(5): 1715 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Clark, Z. Zeng, A. L. Langford, S. M. Bowen, and S. C. Todd PGRL Is a Major CD81-Associated Protein on Lymphocytes and Distinguishes a New Family of Cell Surface Proteins J. Immunol., November 1, 2001; 167(9): 5115 - 5121. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |